Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Editas Medicine Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Scholar Rock Holding Corporation June 27, 202490.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Scholar Rock Holding Corporation | Open-market sale | −12,246 | $49.57 | $607,034 |
| Feb 9, 2026 | Scholar Rock Holding Corporation | Grant or award | +47,021 | — | — |
| Jan 13, 2026 | Scholar Rock Holding Corporation | Open-market sale | −20,438 | $42.70 | $872,703 |
| May 29, 2025 | Scholar Rock Holding Corporation | Open-market sale | −5,130 | $29.63 | $152,002 |
| May 29, 2025 | Scholar Rock Holding Corporation | Open-market sale | −1,620 | $30.01 | $48,616 |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +100,000 | — | — |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +500,000 | — | — |
| Jun 27, 2024 | Scholar Rock Holding Corporation | Grant or award | +13,500 | — | — |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −771 | $184.70 | $142,404 |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,869 | $185.54 | $346,774 |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,107 | $186.39 | $206,334 |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −101 | $187.37 | $18,924 |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −17 | $188.40 | $3,203 |
| Aug 4, 2023 | Alnylam Pharmaceuticals Inc. | Open-market sale | −192 | $189.31 | $36,348 |
| Aug 3, 2023 | Alnylam Pharmaceuticals Inc. | Grant or award | +5,082 | — | — |
Questions about Akshay Vaishnaw
What boards is Akshay Vaishnaw on?
Akshay Vaishnaw sits on the boards of Editas Medicine Inc., Hemab Therapeutics Holdings Inc. and Scholar Rock Holding Corporation.
How long has Akshay Vaishnaw served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.